Predict your next investment

Corporation
ymc.co.jp

See what CB Insights has to offer

Investments

1

About YMC Group

YMC Group is a supplier of separation resins, services and systems for the pharmaceutical market.

YMC Group Headquarter Location

Japan

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest YMC Group News

Thar Process Expands into India’s Markets with YMC India to Focus on Pharma Purification

Aug 19, 2020

PITTSBURGH, Pa., Aug 17, 2020 (SEND2PRESS NEWSWIRE) — Thar Process, Inc – an American manufacturer of high-tech supercritical CO2 extraction and purification equipment – is proud to announce the signing of a new exclusive distribution deal with YMC India (a subsidiary of YMC Co. Ltd., JAPAN). YMC India will now provide Thar’s supercritical extraction and chromatographic systems and expertise to the greater India region. Through this new partnership, Thar Process is furthering their overall mission to design, develop and distribute top-tier quality equipment for the food and pharmaceutical communities, with a dedication and responsibility as an industry leader to help push the emerging market forward and set a higher standard – what Thar calls “Sustainable + Trust.” YMC India proudly leads India in sales of bulk chromatography media and industrial scale chromatography equipment to the world’s largest pharmaceutical manufacturing market. YMC Co. Ltd., JAPAN is internationally reputed for its strong background in stationary phases / chromatographic media for the pharmaceutical industry while also selling preparative to process-scale normal and reverse phase liquid chromatography (LC) equipment. While YMC India will continue to sell those systems, the Thar Process series of SuperFast CO2 Extraction(tm) and Isolator SFC(tm) systems expands their reach into a new markets including the extraction Ayurvedic natural medicines, essential oils, flavors, fragrances; the purification of hemp and palm oil plus chiral separations and impurity remediation for pharmaceuticals. The partnership between Thar Process and YMC India brings together knowledgeable and experienced engineering with the highest level of pharmaceutical industry-specific expertise to further advance the evolving technology and provide innovative products to the South Asian market. About Thar Process Thar is committed to bringing innovation to the industry and providing a reliable source for all natural product oil extraction needs, providing clients the training and education to become a premium FDA registered, USDA Organic processor – like Thar in its Pittsburgh HQ. About YMC India YMC India Pvt. Ltd is a subsidiary of YMC Co. Ltd., JAPAN. with its head office at New Delhi and sales network PAN India. YMC India hold its strong presence throughout the pharmaceutical industry with its diversified product portfolio having column chemistry, Bulk Media, Flash chromatography, large scale HPLC purification systems and large-scale DAC columns and other lab consumables coupled with a highly qualified & dedicated workforce of 50 people. YMC India owns a Custom Purification LAB at Hyderabad where all the application support to our end user is provided.

YMC Group Investments

1 Investments

YMC Group has made 1 investments. Their latest investment was in PeptiStar as part of their Corporate Minority on December 12, 2020.

CBI Logo

YMC Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/1/2020

Corporate Minority

PeptiStar

$17.08M

Yes

1

Date

12/1/2020

Round

Corporate Minority

Company

PeptiStar

Amount

$17.08M

New?

Yes

Co-Investors

Sources

1

YMC Group Acquisitions

2 Acquisitions

YMC Group acquired 2 companies. Their latest acquisition was ChomaCon on April 10, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/10/2019

Acquired

1

12/21/2018

Acquired Unit

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/10/2019

12/21/2018

Investment Stage

Acquired Unit

Companies

Subscribe to see more

Valuation

Total Funding

$99M

Note

Acquired

Subscribe to see more

Sources

1

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.